Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
UPDATE: Canaccord Genuity Upgrades Sarepta Therapeutic (SRPT) to Buy
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
Canaccord Genuity Downgrades Sarepta Therapeutic (SRPT) to Hold
-
Notable Analyst Rating Changes 07/24: (FTI) (AAPL) (ST) Upgraded; (BRCM) (SRPT) (PLCM) Downgraded
-
Notable Analyst Rating Changes 04/16: (MSFT) (S) (PXD) Upgraded; (SRPT) (SE) (CHRW) Downgraded
-
Notable Analyst Rating Changes 04/09: (CYS) (D) (GPN) Upgraded; (STJ) (PL) (CNQR) Downgraded
-
Canaccord Genuity Starts Sarepta Therapeutic (SRPT) at Buy
-
Sarepta Therapeutics (SRPT) 4.95M Share Offering Priced at $25.25
-
Streetinsider.com's Hot Lunchtime Reads 08/15: (AAPL) (PCLN) (SRPT) (MSFT) (KIOR)

